Status:
COMPLETED
Mixture of Liposomal Bupivacaine and Bupivacaine for TAP Block for Open Hysterectomy
Lead Sponsor:
Henry Ford Health System
Conditions:
Hysterectomy
Eligibility:
FEMALE
18+ years
Phase:
PHASE4
Brief Summary
The goal of this study is to evaluate the effectiveness of different formulations of bupivacaine infiltrated into the transversus abdominis plane (TAP) on post-operative pain management after open abd...
Detailed Description
All eligible patients who consent to the study will be randomized to one of three groups. Group 1 will receive a TAP block with 60 mL 0.25% bupivacaine. Group 2 will receive a TAP block with 20 mL lip...
Eligibility Criteria
Inclusion
- Elective open abdominal hysterectomy with midline incision, age \> 18 years, American Society of Anesthesiologist classification score (ASA classification) 1-3.
Exclusion
- Patient with a chronic pain condition, major unexpected surgical complication, unexpected prolonged intubation, patient refusal, local anesthetic allergy, any contraindication to regional anesthesia, greater than 2 attempts by resident and greater than 1 attempt by staff anesthesiologist for TAP block.
Key Trial Info
Start Date :
March 13 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 30 2019
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT03250507
Start Date
March 13 2017
End Date
January 30 2019
Last Update
December 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Henry Ford Hospital
Detroit, Michigan, United States, 48202